Views & Analysis
Changing Faces - Government and Consultant Hires - March 2025
Normally we dedicate this space to agency and consultancy hires, but …
20712 items found
News
RFK Jr unorthodox vaccine views on show in interview
Robert F Kennedy Jr's controversial views on vaccines were on display …
Market Access
Reuters Europe 2025: Using value propositions to improve access
For Reuters Pharma Europe 2025, pharmaphorum is providing coverage …
News
Pill that can slow breast cancer cleared for NHS use
AstraZeneca's oral therapy Truqap will soon be available for people …
Sales & Marketing
Executing established pharma brand strategy: Key considerations for success
Pharmaceutical companies approach a significant wave of patent …
News
Novartis plans $23bn manufacturing, R&D spend in US
Novartis has announced a massive investment in manufacturing and R&D …
News
FDA plans to phase out animal testing for antibodies
The FDA has said it intends to reduce or replace animal testing of …
News
Alzheon Alzheimer's hopes dented by trial readout
Alzheon has been left sifting through the data of a failed …
Sales & Marketing
Partner Content
The ESG in Life Sciences Summit is coming to the West Coast!
The ESG in Life Sciences Summit West is coming to San Francisco ! ( …
News
EVERSANA adds AI to medical, legal and regulatory reviews
EVERSANA has added another feature to its ORCHESTRATE platform for …
News
Sun Pharma overturns block on alopecia drug launch in US
Sun Pharma successfully removed an injunction in the US on the launch …
News
At-home tablet now an option for NHS bladder cancer patients
The first targeted drug for a common form of bladder cancer that can …
Market Access
New FDA head says no more pharma on advisory committees
The announcement signals a new administration attempting to distance itself from industry, but the actual impact seems small.
Market Access
Sponsored
Bridging research and clinical guidelines – interactive stra...
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Part 7
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
R&D
Supercharging clinical development with RWE – with Recursion...
Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.
Oncology
Life Sciences Industry Report - Part 5
Developments in the oncology space in 2024 brought hope to both industry and patients.
Sales & Marketing
Partner Content
The ESG in Life Sciences Summit is coming to the West Coast!
The ESG in Life Sciences Summit West is coming to San Francisco! (July 8-10, 2025).
R&D
ISPE Singapore Affiliate Conference & Exhibition 2025
The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals.
